Adage Capital Partners
CALA

Adage Capital Partners’s Calithera Biosciences, Inc CALA Stock Holding History

Adage Capital Partners’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-107,500
Closed -$4.69M – 1139
2021
Q3 		$4.69M Sell
107,500
-92,500
-46% -$3.99M 0.01% 838
2021
Q2 		$8.36M Hold
200,000
– – 0.02% 741
2021
Q1 		$9.68M Buy
200,000
+100,000
+100% +$5.82M 0.02% 690
2020
Q4 		$9.82M Buy
+100,000
New +$8.76M 0.02% 596
2020
Q1 		– Sell
-62,550
Closed -$7.14M – 810
2019
Q4 		$7.14M Sell
62,550
-2,450
-4% -$184K 0.02% 578
2019
Q3 		$4.02M Buy
65,000
+5,000
+8% +$400K 0.01% 641
2019
Q2 		$4.68M Buy
60,000
+25,000
+71% +$2.84M 0.01% 622
2019
Q1 		$4.72M Hold
35,000
– – 0.01% 610
2018
Q4 		$2.81M Hold
35,000
– – 0.01% 650
2018
Q3 		$3.67M Hold
35,000
– – 0.01% 655
2018
Q2 		$3.5M Hold
35,000
– – 0.01% 673
2018
Q1 		$4.41M Sell
35,000
-40,000
-53% -$6.24M 0.01% 649
2017
Q4 		$12.5M Sell
75,000
-97,394
-56% -$24.9M 0.03% 539
2017
Q3 		$54.3M Sell
172,394
-33,750
-16% -$10.6M 0.13% 209
2017
Q2 		$61.2M Hold
206,144
– – 0.15% 190
2017
Q1 		$47.6M Buy
206,144
+24,391
+13% +$4.21M 0.12% 235
2016
Q4 		$11.8M Buy
181,753
+25,000
+16% +$1.56M 0.03% 501
2016
Q3 		$10.2M Hold
156,753
– – 0.03% 519
2016
Q2 		$11.6M Hold
156,753
– – 0.03% 484
2016
Q1 		$17.8M Hold
156,753
– – 0.05% 389
2015
Q4 		$24M Hold
156,753
– – 0.06% 333
2015
Q3 		$17M Buy
156,753
+18,469
+13% +$2.39M 0.05% 415
2015
Q2 		$19.7M Hold
138,284
– – 0.05% 412
2015
Q1 		$45.4M Hold
138,284
– – 0.11% 246
2014
Q4 		$55.9M Buy
+138,284
New +$36.1M 0.14% 207

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Adage Capital Partners's CALA Position: Q4 2021 in Review

Adage Capital Partners sold out of Calithera Biosciences, Inc (CALA) in Q4 2021, closing a stake of 107,500 shares — an estimated $4.69M sold.

Adage Capital Partners first reported a position in CALA in Q4 2014 and held it in 25 quarters. The position peaked at $61.2M in Q2 2017. 55 funds tracked by Wall St. Rank hold CALA as of Q4 2021.

  • Adage Capital Partners reported no remaining Calithera Biosciences, Inc position as of Q4 2021 after selling out during the quarter.
  • Adage Capital Partners sold 107,500 Calithera Biosciences, Inc shares in Q4 2021, an estimated $4.69M.
  • Adage Capital Partners first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 25 quarters.
  • Adage Capital Partners's Calithera Biosciences, Inc position peaked at $61.2M in Q2 2017.
  • 55 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2021.

Based on Adage Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.